ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
7,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
8,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
9,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
11,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
15,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
16,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
16,2,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
17,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
19,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
19,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
20,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
21,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
22,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
24,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
25,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
25,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
26,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
26,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
26,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
27,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
27,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
27,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,5,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
27,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
27,7,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
27,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
28,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
30,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
31,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
33,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
34,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
35,2,Nail pitting,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
36,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
37,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
38,1,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
39,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
39,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
40,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
40,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
40,5,Neuromuscular toxicity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
40,6,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
41,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
42,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
43,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
43,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,5,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
43,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
43,9,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,10,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
44,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
44,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
45,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
45,4,Myopathy,Myopathies,Muscle disorders,Musc,N
45,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
47,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
47,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
49,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
